SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-22-000051
Filing Date
2022-08-04
Accepted
2022-08-04 17:28:19
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20220630.htm   iXBRL 10-Q 1349537
2 RULE 13A-14(A) CERTIFICATION exhibit311ceoq22022.htm EX-31.1 10805
3 RULE 13A-14(A) CERTIFICATION exhibit312cfoq22022.htm EX-31.2 10780
4 SECTION 1350 CERTIFICATIONS exhibit321ceocfoq22022.htm EX-32.1 7115
  Complete submission text file 0001787306-22-000051.txt   6892929

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20220630.xsd EX-101.SCH 46569
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20220630_cal.xml EX-101.CAL 56745
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20220630_def.xml EX-101.DEF 267722
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20220630_lab.xml EX-101.LAB 612362
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20220630_pre.xml EX-101.PRE 428805
64 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20220630_htm.xml XML 1088805
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 221137859
SIC: 2834 Pharmaceutical Preparations